Tran , T.B. and Doan, T.K.C. 2026. SOME RISK FACTORS OF CARDIOVASCULAR-METABOLISM AND EVALUATION OF TREATMENT RESULTS WITH EMPAGLIFLOZIN COMBINED METFORMIN IN TYPE 2 DIABETES WITH OVERWEIGHT AND OBESITY. Cantho Journal of Medicine and Pharmacy. 33 (Aug. 2026), 10–16.